← Back to all trials
Not Yet Recruiting
NCT07878208
Immunoprofiling of the Patient Tumor Microenvironment in BCMA Targeted Therapies
Conditions: Myeloma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 50
Sponsor: Odense University Hospital
Location: Aarhus University Hospital Aarhus
Summary
The main goal of the project is to characterize the bone marrow immunological milieu and investigate potential treatment defining events of the tumor microenvironment in relapsed and refractory multiple myeloma (RRMM) patients receiving BCMA-targeted therapies.
Eligibility Criteria
Inclusion Criteria:
* Signed informed consent form.
* Participant age ≥ 18 years.
* Prior diagnosis of multiple myeloma according to the IMWG-criteria.
* Progressive disease as defined by IMWG during and after treatment with a BCMA-targeted therapy.
Exclusion Criteria:
\- Initiated subsequent anti-myeloma treatment before inclusion.
Source: ClinicalTrials.gov (NCT07878208). StuddyBuddy aggregates publicly available trial information.
